Executive Summary
The 50 filings reveal a surge in SPAC activity with 7 new S-1/S-1A registrations (BurTech, RRE, ARC, etc.) signaling renewed blank-check IPO momentum amid favorable market conditions, alongside robust M&A in pharma (Amneal's $1.1B Kashiv deal) and healthcare real estate (NHC's $560M acquisition). Indian filings dominate insolvencies and open offers (9 cases including Kwality Walls 26% open offer at ₹21.33, AAA Tech 26% at ₹101), highlighting distress in real estate/infra but opportunistic takeovers. US period-over-period trends show revenue growth averaging +15% YoY across reporting firms (Gaotu +35%, GE Vernova +16%, Viomi +14.6%, LegalZoom +11%), but mixed profitability with op income declines (Viomi -17.8%) and net losses (Gaotu -$46M). Guidance raises (Amneal EBITDA to $740-770M, +3%) and capital returns (LegalZoom $80M cashback, GE Vernova $1.3B buybacks) bolster bullish signals, while regulatory penalties (Birla ₹4.6Cr) and SPAC terminations (Oak Woods, PlusAI) flag risks. Portfolio-level: Pharma/healthcare outperforms with synergies ($400-500M Amneal), contrasted by flat/declining metrics in Chinese tech (Yalla rev +0.7%). Critical implications: Monitor May-June AGMs/proxies for governance votes and Q4FY26 earnings boards (Bondada Apr27, Kajaria Apr30).
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from April 15, 2026.
Investment Signals(12)
- Amneal Pharmaceuticals↓(BULLISH)▲
Q1 rev $723M +4% YoY, Specialty +23% to $133M, gross margin +750bps to 44.3%, raised FY26 EBITDA $740-770M (+3%), EPS $0.95-1.05, $750M Kashiv acquisition for $300B biosimilars opp
- GE Vernova↓(BULLISH)▲
Q1 rev +16% YoY to $9.3B (equip +25%, services +6%), net income $4.7B (+1766% YoY), op cash $5.2B (+347%), $1.3B buybacks, acquisitions $4.9B
- LegalZoom↓(BULLISH)▲
2025 rev $756M +11% YoY, subs +13% to $492M, adj EBITDA 23% margin, $80M cash returned, strong governance
- Gaotu Techedu↓(BULLISH)▲
FY25 rev +35% YoY to RMB6.1B ($879M), gross profit +34%, net loss improved to RMB323M from RMB1B
- Ulta Beauty↓(BULLISH)▲
DEF14A proposes 2026 Incentive Plan, governance upgrades (declassification, AI group), board FOR all, no perf declines
- Associated Alcohols↓(BULLISH)▲
NCLT-approved SDF acquisition ₹30.85Cr for 3.6L cases bottling cap, ops by Sep2026, top-3 Kerala player
- HIVE Digital↓(BULLISH)▲
$100M 0% notes (upsized), net $95M for GPUs/data centers, exchange premium 17.5% to $2.57
- National Healthcare↓(BULLISH)▲
$560M acquisition of 35 facilities accretive to earnings/cashflow, Q3 2026 close
- Kajaria Ceramics↓(BULLISH)▲
Board Apr30 for Q4FY26 results, dividend, buyback proposal
- Viomi Technology↓(BEARISH)▲
FY25 rev +14.6% YoY to RMB2.4B but op income -17.8% to RMB129M, net flat -1.9%
- Birla Corporation↓(BEARISH)▲
₹4.6Cr penalty for mining violations, appeal planned
- Oak Woods Acquisition↓(BEARISH)▲
Merger termination with Huajin, S-4 revocation, extension needed
Risk Flags(10)
- Ansal Properties (Insolvency)[HIGH RISK]▼
51st CoC meeting no progress, litigations adjourned May8, directors absent, IBBI order stayed
- Baron Infotech (Insolvency)[HIGH RISK]▼
23rd CoC Apr23 for due diligence/29A checks, resolution plan approval pending
- The Hi-Tech Gears (Insolvency)↓[HIGH RISK]▼
NCLAT adjourns CIRP stay to Jul10 2026, ongoing appeal vs Happy Forgings
- Vas Infrastructure (Insolvency)[HIGH RISK]▼
NCLT May7 for Authum resolution plan review
- Gazelle Parent (M&A Risks)[HIGH RISK]▼
S-4 mergers with Galera/Obsidian conditional on $350M cash, losses, dilution risks, no exchange ratio adj
- Plus Automation (Termination)[HIGH RISK]▼
Merger with Churchill Capital IX terminated Apr20 due to market conditions
- Yalla Group↓[MEDIUM RISK]▼
FY25 rev +0.7% flat, op cash -20.4% to $138M, tech dev exp 10% rev
- Shinhan Financial↓[MEDIUM RISK]▼
Loans +3.3% YoY but ACL% 0.91% down YoY, impaired coverage -1087bps to 111.9%, NPL 0.57% flat
- Gaotu Techedu↓[MEDIUM RISK]▼
FY25 net loss RMB323M ($46M), equity down to RMB1.25B, current liab $607M
- KDJ Holidayscapes (Default/Resignations)[MEDIUM RISK]▼
Auditor/dir resignations, name/office change, borrowings to Rs5000Cr pending AGM May21
Opportunities(10)
- Kwality Walls (Open Offer)(OPPORTUNITY)◆
26% open offer at ₹21.33 (IDC fair per vals ₹20.95-21.33), post 61.9% acquisition, trading commenced Feb16
- AAA Technologies (Open Offer)(OPPORTUNITY)◆
26% at ₹101 post 34.38% SPA, demat tendering, IDC fair
- Amneal (Biosimilars)(OPPORTUNITY)◆
Kashiv deal $1.1B +$350M milestones, 12+ launches by 2030, $400-500M synergies H2 2026 close
- BurTech Acquisition (SPAC IPO)(OPPORTUNITY)◆
$100M IPO at $10/unit, 15-21mo combo window, Nasdaq BRKHU
- RRE Ventures (SPAC)(OPPORTUNITY)◆
25M units IPO, sponsor 4.5M private warrants
- National Healthcare (REIT Acq)(OPPORTUNITY)◆
$560M 35 facilities accretive Q3 2026, HSR review
- AGI Greenpac (Investment)(OPPORTUNITY)◆
19.75% MOB AI for ₹4.4Cr, e-comm building materials growth
- Brand Engagement (AI Invest)(OPPORTUNITY)◆
Up to $1M Accelevate for fleet AI, US Patent 12,581,163
- HIVE Digital (Expansion)(OPPORTUNITY)◆
$95M net for GPUs/data centers, cap price $4.92
- Kraneshares Crypto (ETF)(OPPORTUNITY)◆
S-1/A for 13-crypto index ETF, passive exposure no leverage
Sector Themes(6)
- SPAC Renaissance(BULLISH SECTOR)◆
7/50 filings (BurTech, RRE, ARC, Oak Woods term, Archimedes merger, Everest amend, etc.) with IPOs/S-1As, 15-21mo windows, $10/unit std, signaling de-SPAC pickup post-2025 lull, watch redemptions
- Indian Insolvency Wave◆
8 cases (Ansal, Baron, Hi-Tech Gears, Vas Infra, KDJ default, Ansal Fernhill) with CoC/NCLT hearings May-Jul 2026, resolutions pending, opportunistic for acquirers like Associated Alcohols [MIXED, DISTRESS OPP]
- Pharma/Healthcare M&A Boom(BULLISH)◆
Amneal $1.1B biosimilars, Gazelle mergers, NHC $560M facilities, Absci/Ulta proxies, leadership changes (Amgen, Docgo), synergies $400-500M, LOE $300B opp
- Revenue Growth vs Profit Pressure(MIXED)◆
6/10 reporters +15% avg YoY rev (Gaotu 35%, GEV 16%, Viomi 14.6%) but op declines (Viomi -17.8%, Shinhan ACL -9bps), margins mixed (Amneal +750bps outlier)
- Capital Raises/Returns Active(BULLISH ALLOC)◆
$100M HIVE notes, SPAC IPOs $100-250M, GEV $1.3B buybacks, LegalZoom $80M returns, Kajaria buyback prop, but related-party notes (FreeCast $3.4M)
- Proxy/AGM Governance Push(NEUTRAL POSITIVE)◆
10+ DEF14As (Ulta, Absci, Legalzoom, Purple, Kopin, GXO) May-Jun 2026 with indep boards, comp votes, plans; no major declines, AI/cyber focus
Watch List(8)
- Bondada Engineering (Earnings)👁
Board Apr27 for Q4FY26 audited results, trading window closes Apr29 [Apr27]
- Kajaria Ceramics (Buyback/Earnings)👁
Board Apr30 for FY26 results, dividend, buyback prop [Apr30]
- Ulta Beauty (AGM)👁
Jun9 virtual, elect 10 dirs, 2026 plan, comp vote, record Apr13 [Jun9]
- Amneal (M&A Close)👁
Kashiv H2 2026 shareholder/reg approval, synergies track [H2 2026]
- Vas Infrastructure (NCLT)👁
Authum resolution plan hearing May7 [May7]
- Ansal Properties (Litigations)👁
IA hearings vs builders May8 NCLT Delhi [May8]
CIRP stay hearing Jul10 [Jul10]
- Yes Bank (Encumbrance)👁
Deutsche/Axis releases complete (8.5% to 0%), watch shareholding shifts post-Apr20/17
Filing Analyses(50)
22-04-2026
Magnum Ice Cream Company Holdco 1 Netherlands B.V. (Acquirer) together with PACs is launching an open offer to acquire up to 61,08,93,729 fully paid-up equity shares (26.00% of voting share capital) of Kwality Wall’s (India) Limited at ₹21.33 per share, following completion of the underlying transaction acquiring 145,44,12,858 shares (61.90%) on March 30, 2026. The maximum consideration is ₹1303,03,63,239.57, with escrow fully funded (initial ₹210,00,00,000 plus additional ₹1093,03,63,239.57). The IDC deemed the offer price fair and reasonable based on independent valuations of ₹21.33 and ₹20.95 per share, with no material changes or revisions reported.
- ·Equity shares of Target Company received listing approval on February 12, 2026, and commenced trading on February 16, 2026; not considered frequently traded due to no prior trading history.
- ·Underlying transaction consummated via share purchase agreement dated June 25, 2025; Sellers reclassified from promoter to public category per SEBI (LODR) Regulation 31A(10).
- ·Board changes post underlying transaction: Abhijit Bhattacharya and Tahir Toloy Tanridagli appointed as additional non-executive non-independent directors; Ritesh Tiwari resigned.
- ·SEBI observations on DLOF issued April 6, 2026; LOF dated April 10, 2026; IDC recommendation approved April 16, 2026 and published April 17, 2026.
- ·Acquirer now promoter of Target Company post-acquisition; PACs not classified as promoters.
22-04-2026
Ulta Beauty, Inc. filed its definitive proxy statement (DEF 14A) on April 22, 2026, for the virtual Annual Meeting of Stockholders on June 9, 2026, proposing the election of 10 director nominees, amendments to the Certificate of Incorporation to limit officer liability and add forum selection provisions, ratification of Ernst & Young LLP as auditors for fiscal 2026 (ending January 30, 2027), advisory approval of executive compensation, and approval of the 2026 Incentive Award Plan; the Board recommends FOR all proposals. The Board highlights governance enhancements including declassification, annual elections, majority voting, director age limit of 75, and formation of an AI advisory group, with all standing committees composed of independent directors and a non-executive Chair. No performance declines or flat metrics are noted in the filing.
- ·Record date for stockholders: April 13, 2026
- ·Annual Meeting: 10:00 a.m. CDT on June 9, 2026, virtually at www.virtualshareholdermeeting.com/ULTA2026
- ·Voting deadline: 10:59 p.m. CDT on June 8, 2026
- ·Director age limit: 75 (absent Board approval)
- ·Fiscal year 2026 ends: January 30, 2027
- ·Proxy materials available around April 22, 2026 at https://ulta.com/investor
22-04-2026
Amneal Pharmaceuticals announced a definitive agreement to acquire Kashiv BioSciences for $375 million cash and $375 million equity at closing, plus up to $350 million in milestone payments and royalties, to build a fully integrated global biosimilars platform targeting over $300 billion in biologics LOE opportunities, expecting more than 12 commercial biosimilars by 2030. Preliminary Q1 2026 results showed consolidated net revenue of $723 million (+4% YoY), with Specialty net revenue up 23% to $133 million, Affordable Medicines up 2% to $423 million, but AvKARE down 4% to $166 million; gross margin expanded 750 bps to 44.3%. The company raised FY2026 standalone guidance, including Adjusted EBITDA to $740 million-$770 million (from $720 million-$760 million) and Adjusted diluted EPS to $0.95-$1.05.
- ·Transaction expected to close in H2 2026, subject to shareholder and regulatory approvals.
- ·Expected $400M-$500M in financial synergies from acquisition.
- ·CREXONT® contributed $21M, Brekiya® $5M, RYTARY® $44M, UNITHROID® $36M in Q1 Specialty revenue.
- ·FY2026 guidance assumes ~330M weighted-average diluted shares; operating cash flow raised to $350M-$400M.
22-04-2026
BurTech Acquisition Corp II, a newly incorporated Cayman Islands blank check company (SPAC), filed an S-1 registration statement on April 22, 2026, for an IPO of 10,000,000 units priced at $10.00 each, raising $100,000,000 in gross proceeds, with $100,500,000 to be deposited into a trust account. Each unit includes one Class A ordinary share and one redeemable warrant exercisable at $11.50 per share starting 30 days post-business combination or 12 months post-effective date. The underwriters have a 45-day option for 1,500,000 additional units; the sponsor holds 4,928,571 founder shares purchased for $25,000, with a 15-month (extendable to 21 months or more) window to complete an initial business combination.
- ·Nasdaq listing symbols: BRKHU (units), BRKH (Class A shares), BRKHW (warrants); separate trading begins 52 days post-prospectus.
- ·Warrants exercisable on later of 30 days post-initial business combination or 12 months post-effective date; expire 5 years post-combination.
- ·Completion window: 15 months from IPO closing, extendable to 21 months via two 3-month extensions ($0.10 per public share deposited) or indefinitely by shareholder vote to amend articles.
- ·Redemption right for public shares at trust value per share; 15% aggregate redemption limit per shareholder/group without consent if shareholder vote method used.
- ·Founder shares convert to Class A on 1:1 basis post-combination, adjusted to ~29.2% ownership excluding certain issuances.
22-04-2026
Viomi Technology Co., Ltd's annual report for the year ended December 31, 2025, shows consolidated total revenues of RMB 2,428,226 thousand (RMB 2.428 billion), up 14.6% YoY from RMB 2,118,982 thousand in 2024. However, income from operations declined 17.8% YoY to RMB 128,554 thousand due to total operating expenses rising 24.6% YoY to RMB 529,397 thousand, driven by sharp increases in selling and marketing expenses (+31.4%) and other categories. Net income attributable to the Company stood at RMB 141,644 thousand, roughly flat (-1.9%) compared to 2024 continuing operations net income of RMB 144,364 thousand, as 2024 totals were reduced by an RMB 80,950 thousand discontinued operations loss.
- ·Hypothetical taxation scenario assumes 25% statutory tax rate yielding 67.5% net distribution to parent/shareholders after 10% withholding tax.
- ·Certain subsidiaries and VIEs qualify for 15% preferential income tax rate in China, though temporary and subject to review.
- ·Inter-company revenues eliminated in consolidation: RMB 1,539 thousand in 2025 vs RMB 582,002 thousand in 2024.
- ·VIEs and subsidiaries reported net loss of RMB 411 thousand in 2025 vs net income contribution in 2024.
22-04-2026
Ansal Properties & Infrastructure Limited disclosed minutes of the 51st Committee of Creditors (CoC) meeting for its Fernhill Project in Gurgaon, Haryana, held on April 21, 2026, confirming 100% voting rights quorum with participation from homebuyers' representative and an unsecured creditor. The CoC approved minutes of the prior meeting, noted e-voting results, and received updates on ongoing litigations against parties like Samyak Projects and Piyare Lal Builders, all now adjourned to May 8, 2026, with no resolutions passed or financial approvals made. Directors remained absent despite notice, and the insolvency process continues without notable progress.
- ·Ongoing litigations (IA Nos. 2957/2024, 3022/2024, 3245/2024, 1459/2023) against Piyare Lal Builders and Samyak Projects under Sections 66, 43, and 19(2), all listed for hearing on May 8, 2026 at NCLT Delhi.
- ·IBBI order against RP stayed by High Court; effective only after April 30, 2026.
- ·Serene Residency resolution plan approved by NCLT on October 6, 2025.
- ·NCLAT order on January 7, 2026 confined CIRP to Lucknow and Rajasthan projects.
- ·All suspended directors absent from 51st CoC meeting.
22-04-2026
On April 22, 2026, the Board of KDJ Holidayscapes & Resorts Ltd noted resignations of secretarial auditor M/s. Vinay Terse & Associates (due to time constraints) and Non-executive Non-Independent Director/Chairman Mr. Nimeshkumar Ganpatbhai Patel, while approving appointments of M/s. Avni & Associates as secretarial auditor for FY 2025-26 to 2029-30, Ms. Neha Kanwar Bhati as Additional Non-executive Independent Director (also joining Audit and NRC), and Mr. Ravikumar Gaurishankar Patel as new Chairman. The Board approved changing the company name to Avenique Limited, shifting registered office from Mumbai to Ahmedabad, altering MoA (name, objects, registered office clauses) and adopting a new MoA, reconstituting Audit and NRC, and authorizing borrowing/investment limits up to Rs. 5000 Crores each, all subject to shareholder approval at the 32nd AGM on May 21, 2026.
- ·Secretarial auditor resignation effective April 21, 2026.
- ·Director resignation effective close of business hours on April 22, 2026.
- ·New appointments effective April 22, 2026.
- ·M/s. Dharti Patel & Associates appointed as e-voting scrutinizer for AGM.
- ·Board meeting duration: 05:00 P.M. to 06:00 P.M. on April 22, 2026.
- ·Old registered office: 228/5-B, Akshay Mittal, Mittal Industrial Estate, Andheri Kurla Road, Marol, Andheri (East), Mumbai - 400059.
- ·New registered office: A-1217 Titanium Business Park, B/h Divyabhaskar Press, Makarba, Jivraj Park, Ahmedabad - 380051.
22-04-2026
Absci Corporation (ABSI) filed its DEF 14A proxy statement for the virtual Annual Meeting of Stockholders on June 4, 2026, at 9:00 a.m. ET, with a record date of April 7, 2026, when 155,447,428 shares of common stock were outstanding, requiring a quorum of 77,723,715 shares. The meeting includes Proposal 1 (election of Class II directors, non-routine) and Proposal 2 (ratification of Ernst & Young LLP as independent auditors for the year ending December 31, 2026, routine). The company qualifies as an emerging growth company until the earliest of December 31, 2026, $1.235 billion annual gross revenue, $1 billion in nonconvertible debt over three years, or $700 million public float triggering large accelerated filer status.
- ·Proxy materials available on or about April 22, 2026, via www.proxyvote.com or www.sec.gov.
- ·Voting deadline: 11:59 p.m. ET on June 3, 2026, for Internet/telephone/mail; live voting at virtual meeting.
- ·Corporate address: 18105 SE Mill Plain Blvd, Vancouver, WA 98683, Attention: Corporate Secretary.
- ·Technical support for virtual meeting: (844) 986-0822 (U.S.) or (303) 562-9302 (International).
22-04-2026
Amgen announced the retirement of David M. Reese, M.D., Executive Vice President and Chief Technology Officer, effective June 30, 2026, following his contributions to innovative medicines, biosimilars, pipeline advancement, and early adoption of AI in R&D since joining in 2005. Effective June 1, 2026, organizational changes to emphasize convergent innovation include appointing James Bradner, M.D., as EVP Research and Development, Artificial Intelligence and Data; Sean Bruich as SVP Chief Technology Officer; Murdo Gordon as EVP Amgen Global Markets and Policy; with Paul Burton, M.D., Ph.D., continuing as SVP Chief Medical Officer. These adjustments aim to integrate biology, data science, and advanced technologies to accelerate medicine discovery and enhance patient engagement.
- ·David M. Reese joined Amgen in 2005 as clinical development leader in oncology; served as EVP R&D from 2018 to 2023.
- ·Amgen part of Dow Jones Industrial Average and Nasdaq-100 Index.
- ·Contacts: Elissa Snook (media, 609-251-1407); Casey Capparelli (investors, 805-447-1746).
22-04-2026
LegalZoom.com, Inc. reported strong 2025 financial performance with revenue of $756M (+11% YoY), subscription revenue of $492M (+13% YoY), and transaction revenue of $264M (+7% YoY), alongside net income of $15M (2% margin) and adjusted EBITDA of $172M (23% margin), while returning ~$80M in cash to stockholders. The 2026 annual meeting on June 3 seeks stockholder approval for electing Sivan Whiteley as Class II director, ratifying the independent auditor, and an advisory vote on NEO compensation, following governance enhancements responsive to stockholder feedback including revised PSU metrics focused on revenue growth and relative TSR. The Board demonstrates strong independence (5/6 independent directors) and oversight of key risks like AI and cybersecurity.
- ·Annual Meeting date: June 3, 2026 at 9:00 a.m. PT (virtual at www.proxydocs.com/LZ)
- ·Record date: April 9, 2026
- ·Proposals: (1) Elect Sivan Whiteley as Class II director (term until 2029), (2) Ratify independent auditor, (3) Advisory vote on NEO compensation
- ·Board composition: Classified board with staggered terms; average tenure ~5 years; 2/6 female directors; 1 LGBTQ+ director
- ·2026 PSU changes: 70% PSUs (revenue growth + relative TSR vs. Nasdaq Composite over 3 years) and 30% RSUs for CEO
- ·Corporate governance: Clawback policy, anti-hedging/pledging, director stock ownership 5x retainer, single class shares
22-04-2026
Gazelle Parent, Inc. filed an S-4 registration statement on April 22, 2026, for mergers with Galera and Obsidian, conditioned on, among other things, receipt of at least $350 million in cash proceeds from a subscription agreement and stockholder approvals. Both Galera and Obsidian are clinical-stage biopharma companies reporting significant historical and expected future losses, heavy reliance on unapproved product candidates tilarginine and OBX-115, respectively, and potential need for additional capital post-merger, which could dilute stockholders. The mergers face numerous risks, including no adjustment to exchange ratios based on market prices, possible lawsuits, and CVRs that may expire valueless.
- ·Merger conditions include Nasdaq listing approval for Parent common stock, no Material Adverse Effect on Galera or Obsidian, and continued OTCQB listing for Galera shares.
- ·Merger agreement includes non-solicitation provisions, with limited exceptions for superior offers prior to stockholder approval.
- ·Directors and executives of Galera and Obsidian have interests differing from stockholders, including severance benefits and equity treatment.
22-04-2026
RRE Ventures Acquisition Corp., a blank-check SPAC, filed an S-1/A registration statement on April 22, 2026, for an IPO of 25,000,000 units (assuming no over-allotment and 1,250,000 founder shares surrendered), each comprising one Class A ordinary share and one-third of one warrant exercisable at $11.50 per share. Post-offering, the company expects 33,333,333 Class A ordinary shares and 15,343,333 warrants outstanding, including 8,333,333 public warrants, 4,510,000 private placement warrants to sponsor RRESponsor LLC, and 2,500,000 to the underwriter. The sponsor provided an initial $25,000 investment and holds founder shares, of which 2,748,000 Class B shares were sold to management and affiliates.
- ·Registration No. 333-294904
- ·Warrants exercisable 30 days after initial business combination completion; expire 5 years thereafter
- ·Warrant exercise price: $11.50 per share (adjustable under certain conditions to 115% of higher of Market Value or Newly Issued Price)
- ·Public warrants redeemable at $0.01 each if Class A share price >= $18.00 for 20 trading days in 30-day period (beginning 120 days post-business combination)
- ·Up to 1,250,000 founder shares subject to surrender based on underwriter over-allotment exercise
- ·Separate trading of shares and warrants prohibited until post-closing Form 8-K with audited balance sheet filed
22-04-2026
Deutsche Bank AG group, along with PACs including DB Trustees (Hong Kong) Limited, disclosed under SEBI Regulation 29(2) the release of encumbrance on 2,664,580,360 shares (8.49% of total share capital, 8.39% diluted) of YES Bank Limited effective April 17, 2026, reducing their total holding from 2,677,558,246 shares (8.53%) to 12,977,886 shares (0.04%). This release pertains to security created under a facility agreement dated April 24, 2023, for Verventa Holdings Ltd, with prior disclosures made on June 5, 2025, and September 24, 2025. Post-release, no encumbrance remains with the acquirer.
- ·Facility agreement dated 24 April 2023 between Verventa Holdings Ltd and certain lenders.
- ·Share charge dated 19 July 2023 by Verventa Midco Limited in favor of DB Trustees.
- ·Disclosure triggered as release resulted in >2% change in encumbrance shareholding.
- ·Previous disclosures: 5 June 2025 and 24 September 2025.
22-04-2026
IIFL Capital Services Limited (formerly IIFL Securities Limited) issued a clarification on April 22, 2026, in response to BSE and NSE queries regarding a media report on NDTV Profit dated April 21, 2026. The company denied any ongoing negotiations or undisclosed information requiring disclosure under Regulation 30 of SEBI LODR, stating it routinely explores strategic opportunities but has no material developments to announce. It affirmed commitment to regulatory compliance and transparency.
- ·Media report published on https://www.ndtvprofit.com/ dated April 21, 2026.
- ·BSE reference: L/SURV/ONL/RV/SG/(2026-2027)/11 dated April 21, 2026.
- ·NSE reference: No. 16886 dated April 21, 2026.
- ·No regulatory/legal proceedings applicable to the news item.
22-04-2026
Bondada Engineering Limited (Scrip Code: 543971) has informed BSE Limited that a Board of Directors meeting is scheduled for April 27, 2026, at its corporate office in Hyderabad to approve the Audited Financial Results (Standalone & Consolidated) for Q4 FY 2025-26 and the full year ended March 31, 2026. The trading window for company shares remains closed from April 1, 2026, until April 29, 2026, per SEBI (LODR) Regulations.
- ·Meeting venue: C-26, Kushaiguda Industrial Area, Kushaiguda, ECIL, Hyderabad-500062
- ·CIN: L28910TG2012PLC080018
- ·Company website: www.bondada.net
- ·Prior trading window notice: March 26, 2026
22-04-2026
Jyotirgamya Advisory Private Limited (Acquirer 1) and Mr. Ashok Kumar Chordia (Acquirer 2) are launching an open offer to acquire up to 33,34,968 fully paid-up equity shares of ₹10 each of AAA Technologies Limited at ₹101 per share, representing 26.00% of the voting share capital, following a Share Purchase Agreement for 44,10,000 shares (34.38%). The Committee of Independent Directors deems the offer price fair and reasonable based on reviewed documents, though shareholders are advised to evaluate independently. All shares are held in dematerialized form, with tendering via stock exchange mechanism during the tendering period.
- ·Identified Date: April 08, 2026 (for determining public shareholders eligible to receive LoF)
- ·Letter of Offer dispatched electronically on April 13, 2026 and physically on April 16, 2026
- ·IDC recommendation published on April 20, 2026
- ·No statutory approvals required as on date; offer withdrawable if approvals become necessary and not received
- ·Existing promoters to be reclassified as public shareholders post-open offer
- ·No physical equity shares outstanding
- ·Offer not withdrawable if SPA terminated
22-04-2026
The Board of Directors of iCodex Publishing Solutions Limited, in its meeting on April 22, 2026, approved availing credit facilities aggregating to Rs. 10,80,00,000 from ICICI Bank, Viman Nagar Branch, for working capital, general corporate purposes, and capex. The borrowings are within the limits under Section 180(1)(c) of the Companies Act, 2013, and will involve creation of charge on company assets in compliance with Section 180(1)(a). The board meeting commenced at 12:00 p.m. and concluded at 12:30 p.m.
- ·ISIN: INE111601014
- ·Scrip code: 544483
- ·CIN: L72900PN2018PLC176870
22-04-2026
Associated Alcohols & Breweries Limited (AABL) received NCLT Kochi Bench approval on April 16, 2026, for its resolution plan to acquire SDF Industries Ltd., a distillery-cum-bottling unit in Thrissur, Kerala, at a cost of ₹30.85 crore, making it a wholly-owned subsidiary. SDF offers IMFL bottling capacity of ~3.60 lakh cases per annum and ENA distillery capacity of 75 lacs liters per annum on 10 acres of land. The acquisition enables in-house bottling for AABL's Kerala brands like Lemount White Brandy, with operations targeted to commence by September 2026 to enhance efficiency and support growth.
- ·AABL entered Kerala market in 2018 and ranks among top 3 private players in the state.
- ·SDF facility located on Thrissur-Palakkad border, well-connected to Kochi, Coimbatore, and Calicut airports.
- ·Press release issued on April 22, 2026, following prior communications on April 16 and 20, 2026.
22-04-2026
Pine Labs Limited confirmed entering into a commercial agreement with Karnataka Bank Limited for retail payment solutions, including point-of-sale services, following a news item published on April 21, 2026, via Karnataka Bank's press release. The partnership is an incremental addition to Pine Labs' existing portfolio of bank alliances, strengthening its position in the Indian banking ecosystem, particularly in southern India, and aligns with its core business model. The company stated the arrangement is in the ordinary course of business, not material under SEBI Regulation 30 or its Materiality Policy, with no Unpublished Price Sensitive Information or regulatory proceedings.
- ·No regulatory or legal proceedings initiated, pending, or concluded relating to the matter.
- ·Arrangement assessed as not requiring separate exchange filing due to ordinary course nature and absence of UPSI.
- ·Company confirms compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and no undisclosed information explaining securities price/volume movement.
22-04-2026
Baron Infotech Limited, currently under Corporate Insolvency Resolution Process (CIRP), has notified BSE of its 23rd Committee of Creditors (CoC) meeting scheduled for April 23, 2026, at 6:00 PM IST. The meeting will deliberate on the due diligence report for Resolution Applicants and connected persons under Section 29A of the Insolvency and Bankruptcy Code, 2016, and consider approving a Resolution Plan. This disclosure complies with Regulation 30 and Schedule III of SEBI (LODR) Regulations, 2015.
- ·BSE Scrip Code: 532334
- ·CIN: L72200TG1996PLCO25855
- ·RP Office: Flat No. 113, Block - B, Sri Datta Sai Commercial Complex, RTC X’ Roads, Hyderabad - 500 020
- ·Contact: Phone No: 040-27623101; Mail Id: ip.baroninfotech@gmail.com
22-04-2026
Kajaria Ceramics Limited has informed BSE and NSE that a Board of Directors meeting is scheduled for April 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026, recommend dividend if any, and approve a proposal for buyback of equity shares subject to regulatory approvals. The trading window for dealing in the company's securities will remain closed until 48 hours after submission of the board meeting outcome to the exchanges.
- ·Notice issued in terms of Regulation 29 of SEBI (LODR) Regulations, 2015
- ·Trading window closure references earlier letter dated March 25, 2026, pursuant to Company's Code of Conduct for Prevention of Insider Trading and SEBI (PIT) Regulations, 2015
22-04-2026
Birla Corporation Limited received an order dated 21st April 2026 from the Department of Mines & Geology, Chittorgarh, Rajasthan, imposing a penalty of ₹4,59,92,229 and a compounding fee of ₹1,00,000 (total ₹4,60,92,229) for alleged mining activities in restricted areas not conforming to the mining lease conditions. The company disputes the order, asserting that operations were lawful, and intends to file an appeal or writ petition in the Rajasthan High Court. No immediate financial or operational impact is acknowledged pending appeal.
- ·Order received by company officer on 21st April 2026 at 4:03 p.m. IST
- ·Disclosure pursuant to Regulation 30 of SEBI LODR Regulations, 2015
- ·Authority: Mining Engineer, Department of Mines & Geology, Chittorgarh, Rajasthan
22-04-2026
AGI Greenpac Limited has completed the second tranche investment in Madoverbuilding AI Private Limited (MOB AI), acquiring an aggregate 19.75% stake (on fully diluted basis) for a total consideration of INR 4,42,95,193.28, following Tranche 1 on May 30, 2025 and a revision from an initial 25% target. MOB AI, an e-commerce platform for building materials, reported FY 2024-25 turnover of INR 3.25 crore, a slight decline from INR 3.36 crore in FY 2023-24 but up significantly from INR 1.48 crore in FY 2022-23.
- ·MOB AI incorporation date: December 21, 2021
- ·Tranche 2 allotment approved by MOB AI Board on April 21, 2026
- ·No governmental or regulatory approvals required
- ·Acquisition not a related party transaction
22-04-2026
Senco Gold Limited informed the stock exchanges about the newspaper publication of a notice on April 22, 2026, in Business Standard (English) and Dainik Statesman (Bengali) regarding the Second 100 days campaign 'Saksham Niveshak' by the Investor Education and Protection Authority. The publication aims to create awareness among shareholders for claiming unclaimed or unpaid dividends, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. No financial impacts or performance metrics were disclosed.
- ·Publication date: April 22, 2026
- ·Membership No. of Mukund Chandak: A20051
- ·NSE Symbol: SENCO; BSE Scrip Code: 543936
22-04-2026
The Hi-Tech Gears Limited updated on the Corporate Insolvency Resolution Process (CIRP), informing that the Hon'ble NCLAT adjourned the hearing from April 20, 2026, to July 10, 2026, due to paucity of time. The interim stay on the CIRP process, originally granted on September 03, 2024, continues as per the NCLAT order dated February 18, 2026. This pertains to Company Appeal (AT) (Insolvency) No. 1734 of 2024 & I.A. No. 2735 of 2025 filed by Naveen Jain against Happy Forgings Ltd.
- ·NCLAT order uploaded on NCLAT website on April 22, 2026.
- ·Previous NCLAT order reference: February 18, 2026, with next hearing originally fixed for April 20, 2026.
- ·Corporate Identification Number (CIN): L29130HR1986PLC081555.
- ·NSE Stock code: HITECHGEAR; BSE Stock code: 522073.
22-04-2026
Gaotu Techedu Inc. reported net revenues of 6,146,772 RMB thousand ($878,977 thousand USD) for the year ended December 31, 2025, marking a 35% YoY increase from 4,553,556 RMB thousand, driven by strong gross profit growth of 34% to 4,145,079 RMB thousand ($592,739 thousand USD). However, the company recorded a net loss of 323,307 RMB thousand ($46,232 thousand USD), an improvement from 1,048,954 RMB thousand in 2024 but still reflecting ongoing unprofitability, with shareholders' equity declining to 1,253,745 RMB thousand ($179,284 thousand USD) from 1,933,464 RMB thousand. Total assets grew modestly to 6,199,686 RMB thousand ($886,544 thousand USD), while cash and equivalents decreased to 596,195 RMB thousand ($85,255 thousand USD).
- ·Selling expenses decreased to 3,289,064 RMB thousand in 2025 from higher prior years but remained elevated at RMB equivalent $470M.
- ·Total current liabilities rose to 4,245,487 RMB thousand ($607M) as of Dec 31 2025.
- ·Hypothetical net distribution to Parent/Shareholders at 67.5% after taxes in Table 1.
22-04-2026
AUNA S.A., a healthcare provider in Latin America, filed its 20-F Annual Report on April 22, 2026, detailing its business overview, risk factors, and operations across Peru, Mexico, and Colombia. The report emphasizes a technologically enabled platform including the Auna App for patient services like telehealth and digital pharmacy, amid regional challenges such as deficient public healthcare infrastructure and low private insurance penetration. Plan sales channels included partnerships with credit card companies (8.3%) and major insurers/brokers (63%) for the year ended December 31, 2025, with no period-over-period financial performance data provided in the excerpts.
- ·Dividend payments restricted under Luxembourg law: distributions may not exceed results of last financial year plus carried forward profits/reserves minus losses/undistributable reserves.
- ·Utilization rate defined as (total patient-days / total beds) x total days in period; higher utilization drives revenue and margins due to fixed costs.
- ·Regional issues include deficient public/private healthcare, low insurance penetration, and conflicts of interest leading to opaque costs.
22-04-2026
Purple Innovation, Inc. (PRPL) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 9, 2026, at 10:00 a.m. Mountain Time, seeking approval to elect eight directors, an advisory vote on executive compensation, and ratification of BDO USA, P.C. as independent auditors for the year ending December 31, 2026. The record date is April 13, 2026, with 108,825,636 Class A shares and 163,052 Class B shares outstanding, totaling 108,988,688 votes eligible. No financial performance metrics are discussed.
- ·Annual Meeting registration deadline: June 7, 2026, at 5:00 p.m. Eastern Time at https://register.proxypush.com/PRPL.
- ·Quorum requires majority of voting power of outstanding Common Stock.
- ·Proposal 1 (director election) and Proposal 2 (exec comp) are non-routine; brokers cannot vote uninstructed shares. Proposal 3 (auditor ratification) is routine.
- ·Proxy materials available at https://annualgeneralmeetings.com/prpl2026.
22-04-2026
On April 17, 2026, Stephen K. Klasko, MD notified DocGo Inc. of his decision to step down from the Board and committees effective at the conclusion of the 2026 Annual Meeting on June 16, 2026, due to a new healthcare leadership role, with no disagreements on company matters. The Board appointed Michael Burdiek as independent Chair and Jim Travers to the Audit and Compliance Committee and Nominating and Corporate Governance Committee, effective around the same time. On April 21, 2026, the Board formed a special committee chaired by Mr. Burdiek with Vina Leite and Ira Smedra to identify corporate efficiencies and cost reductions to accelerate profitability.
- ·Dr. Klasko joined the Board in October 2024.
- ·Special committee appointments effective immediately on April 21, 2026.
22-04-2026
Kopin Corporation's DEF 14A proxy statement solicits votes for its 2026 Annual Meeting on May 21, 2026, including election of five directors for terms expiring at the 2027 meeting, approval of the amendment and restatement of the 2020 Equity Incentive Plan, ratification of BDO USA, P.C. as independent auditors for the fiscal year ending December 26, 2026, and advisory approval of named executive officer compensation for the fiscal year ended December 27, 2025. The record date is March 26, 2026, with 183,476,366 shares of common stock and 1,000 shares of Series A convertible preferred stock (convertible into 2,333,333 common shares) outstanding and entitled to vote. No financial performance metrics or period-over-period changes are detailed beyond standard governance disclosures.
- ·Meeting location: offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110, at 10:00 a.m. Eastern Time
- ·Proxy materials mailed on or about April 20, 2026
- ·Internet and telephone voting closes at 11:59 p.m. ET on May 20, 2026
22-04-2026
HIVE Digital Technologies Ltd. announced the upsizing and pricing of a private offering of US$100 million aggregate principal amount of 0% exchangeable senior notes due 2031 (upsized from US$75 million), issued by its subsidiary HIVE Bermuda 2026 Ltd., with an option for initial purchasers to buy an additional US$15 million. The notes carry an initial exchange price of approximately US$2.57 per common share (17.5% premium to the April 16, 2026 Nasdaq closing price) and net proceeds of approximately US$95 million (or US$109.5 million if option exercised) will fund general corporate purposes, capital investments including GPUs, and data center development. The company also entered capped call transactions with a cap price of US$4.92 per share (125% premium to closing price), funded partly by US$17.2 million in cash on hand.
- ·Notes mature on April 15, 2031; exchangeable starting under certain conditions prior to January 15, 2031.
- ·Expected closing date: April 21, 2026, subject to customary conditions.
- ·Holders can require repurchase on April 15, 2029, or upon fundamental change.
- ·Issuer may redeem prior to April 20, 2029 only on tax events; after April 20, 2029 if share price >=130% of exchange price.
- ·Common shares expected to cease trading on TSXV and commence on TSX around April 30, 2026; TSX listing conditional by June 30, 2026.
- ·Capped call transactions to reduce dilution upon exchange, subject to anti-dilution adjustments.
22-04-2026
Didier Papadapoulos, President of Aircraft OEM at Joby Aviation, Inc., notified the company of his resignation effective July 3, 2026, to spend time with family and pursue personal interests after five years leading aircraft development efforts. The departure is not due to any disagreement with the company, which expressed gratitude for his contributions and expects him to provide ongoing advisory services.
- ·Resignation notification date: April 20, 2026
- ·Filing signed on April 21, 2026
- ·SEC filing date: April 22, 2026
22-04-2026
National Healthcare Corporation (NHC) entered a Purchase and Sale Agreement to acquire real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors, Inc. (NHI) for $560 million, expected to close in Q3 2026 and be accretive to earnings and cash flow. NHC currently leases and operates most of these facilities and will continue doing so post-acquisition, except for four Florida skilled nursing facilities which will be leased to a third-party operator. The transaction is subject to customary closing conditions including HSR antitrust review, with risks of termination or delays noted.
- ·Facilities located in Alabama, Florida, Kentucky, Missouri, South Carolina, Tennessee, and Virginia
- ·Subject to Hart-Scott-Rodino Antitrust waiting period
- ·NHC operates under prior Master Agreement to Lease with NHI
22-04-2026
Oak Woods Acquisition Corp terminated its Merger Agreement with Huajin (China) Holdings Limited, originally signed on August 11, 2023, effective April 16, 2026, following a settlement on March 15, 2026, with no fees or penalties payable by either party. The company is revoking its Registration Statement on Form S-4 (No. 333-280240), filed June 14, 2024, and related proxy solicitation, canceling the planned extraordinary general meeting and proxy solicitation for the Business Combination. It plans to file for a shareholder extension of its business combination deadline, amid risks of failing to complete a deal or meet Nasdaq listing standards.
- ·Registration Statement File No. 333-280240 filed June 14, 2024
- ·Company filing Form RW to withdraw Registration Statement and proxy
- ·Securities previously registered on no current exchange listing
22-04-2026
ARC Group Acquisition I Corp., a British Virgin Islands-incorporated SPAC, filed Amendment No. 6 to its Form S-1 registration statement on April 22, 2026, solely to include new exhibits such as legal opinions (Exhibits 5.1, 5.2) and the filing fee table (Exhibit 107), with no changes to the prospectus. Estimated expenses for the offering total $700,000, including $225,000 in legal fees and $80,000 in Nasdaq listing fees. The sponsor, MFH 2, LLC, holds 5,175,000 Class B ordinary shares (originally purchased for $25,000, after surrenders) and has committed to purchasing 200,000 private units for $2,000,000.
- ·Sponsor initially purchased 12,321,429 Class B shares for $25,000 on May 27, 2025; surrendered 4,928,572 on December 3, 2025, and 2,217,857 on April 6, 2026.
- ·Founder shares represent 28.8% of outstanding shares post-offering (assuming full exercise of 12,075,000 unit over-allotment).
- ·Registrant qualifies as a non-accelerated filer, smaller reporting company, and emerging growth company.
- ·Offering to be listed on Nasdaq; continuous offering pursuant to Rule 415.
22-04-2026
Archimedes Tech SPAC Partners II Co. (ATII) entered into a Merger Agreement on April 20, 2026, with Forge Nano, Inc., involving ATII's subsidiaries ATII Holdings Inc., ATII Merger Sub Inc., and ATII Merger Sub II, LLC, as previously announced. The filing furnishes a press release dated April 21, 2026, under Item 7.01, emphasizing forward-looking statements about the proposed business combination while highlighting extensive risks such as shareholder approval failures, redemptions, operational disruptions, and regulatory changes that could prevent closing or impact benefits.
- ·Merger Agreement dated April 20, 2026; Filing date April 22, 2026; Earliest event reported April 21, 2026
- ·ATII securities: ATIIU (Units), ATII (Ordinary Shares), ATIIW (Warrants) on Nasdaq
- ·ATII is a Cayman Islands exempted company and emerging growth company
- ·Registration Statement on Form S-4 to be filed, including proxy statement/prospectus
22-04-2026
Churchill Capital Corp IX and Plus Automation, Inc. (PlusAI) mutually terminated their Agreement and Plan of Merger and Reorganization, originally entered on June 5, 2025, effective April 20, 2026, citing market conditions. The termination involves AL Merger Sub I, Inc. and AL Merger Sub II, LLC as subsidiaries of Churchill. No financial terms or impacts from the termination are disclosed.
- ·Filing Date: April 22, 2026
- ·Registrant CIK: 0002086744
- ·IRS Employer Identification No.: 93-2913093
- ·Principal Executive Offices: 3315 Scott Boulevard, Suite 300, Santa Clara, California 95054
22-04-2026
FreeCast, Inc. entered into a Renewal Revolving Convertible Promissory Note on April 20, 2026, with Nextelligence, Inc. (controlled by CEO William A. Mobley, Jr.), renewing a prior note up to $5M principal, with $5,114,052 outstanding as of the effective date. Nextelligence converted $1,714,052 of principal into 484,354 shares of Class A common stock, reducing the outstanding principal to $3,400,000 at 12% interest, due June 30, 2027; however, the note remains a significant related-party obligation with potential default rate of 18%. The shares were issued in an unregistered transaction exempt under Sections 4(a)(2) and 3(a)(9) of the Securities Act.
- ·Note interest rate: 12% per annum; default rate: 18% per annum.
- ·Maturity date: June 30, 2027.
- ·Conversion price: closing price of Class A common stock on Nasdaq on most recent trading day prior to conversion notice.
- ·Company has right to prepay with 5 days prior notice.
- ·Shares issued exempt under Sections 4(a)(2) and 3(a)(9) of Securities Act; Nextelligence is accredited investor.
22-04-2026
Everest Consolidator Acquisition Corporation filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, modifying Section 9.1(b) of Article IX to permit withdrawal of interest earned on the Trust Account on or after January 20, 2026, for Permitted Expenses including taxes, legal costs, insurance, audits, and working capital related to seeking a business combination. The amendment was adopted by the Board of Directors and approved by stockholders in accordance with Delaware law. This change enhances liquidity access without releasing principal, supporting extended operations toward a potential business combination.
- ·Original Certificate of Incorporation filed: March 8, 2021
- ·Amended and Restated Certificate filed: November 23, 2021
- ·Amendment signed: April 20, 2026
- ·Registration Statement initially filed: October 18, 2021
22-04-2026
David P. Millis, President of Millis Transfer and a director of Heartland Express, Inc., informed the company of his retirement from the presidency effective April 24, 2026, while continuing to serve as a director. In connection with his retirement, Mr. Millis will receive compensation and insurance benefits totaling $66,766 and 4,866 shares of common stock. Post-retirement, he will be eligible for standard non-employee director compensation as outlined in the company's 2026 proxy statement filed on April 2, 2026.
- ·Informed the company of retirement decision on April 16, 2026
- ·8-K filed on April 22, 2026, signed April 21, 2026
- ·Director compensation details in proxy statement filed April 2, 2026
22-04-2026
Spruce Biosciences, Inc. (NASDAQ: SPRB) announced a proposed underwritten public offering of shares of its common stock or pre-funded warrants, with joint book-running managers Leerink Partners, Guggenheim Securities, and Oppenheimer & Co., and co-managers Jones and Craig-Hallum. The company expects to grant underwriters a 30-day option to purchase up to 15% additional shares at the public offering price, less discounts. The offering is subject to market conditions, with no assurance on completion, size, or terms, and is made pursuant to a shelf registration on Form S-3 effective November 26, 2025.
- ·Shelf registration on Form S-3 filed October 29, 2025, declared effective November 26, 2025.
- ·Announcement date: April 20, 2026.
- ·SEC filing date: April 22, 2026.
22-04-2026
Brand Engagement Network, Inc. (BEN) announced a strategic investment of up to $1,000,000 in Accelevate Solutions, including an initial $250,000 payment, via a binding term sheet to advance AI in fleet operations and establish in-vehicle engagement channels. The collaboration integrates BEN's AI with Accelevate's fleet infrastructure, targeting the commercial fleet market with billions in tech spend, supported by BEN's newly granted U.S. Patent No. 12,581,163. No declines or flat metrics reported.
- ·U.S. Patent No. 12,581,163 titled 'Systems and Methods for Delivering User-Specific Messages' granted to BEN.
- ·Accelevate platform available on Geotab Marketplace and integrates with MyRadar.
- ·Sources: Geotab State of Commercial Transportation Report (2024); International Energy Agency (IEA) Global EV Outlook.
22-04-2026
GE Vernova Inc. reported robust Q1 2026 results with total revenues increasing 16% YoY to $9,339 million from $8,032 million, driven by 25% growth in equipment sales to $5,254 million and 6% in services to $4,084 million. Net income attributable to GE Vernova surged to $4,745 million from $254 million, propelled by $4,762 million in other income (Note 19), though operating income grew more modestly to $179 million (+316% YoY) amid higher SG&A (+9%) and R&D expenses (+27%). Cash from operating activities rose to $5,188 million from $1,161 million, supporting $4,886 million in principal business acquisitions, with total assets expanding 20% QoQ to $75,612 million.
- ·Goodwill increased to $9,855 million from $4,439 million QoQ due to acquisitions.
- ·Long-term borrowings rose to $2,806 million from $265 million QoQ.
- ·Treasury common stock at cost increased to $(4,684) million from $(3,385) million QoQ amid $1,299 million repurchases.
- ·Dividends declared at $0.50 per common share, totaling $137 million.
22-04-2026
Shinhan Financial Group's total gross loans grew to W 469,768 billion as of December 31, 2025, up 3.3% YoY from W 455,125 billion in 2024 and 9.0% from W 417,346 billion in 2023. However, the allowance for credit losses as a percentage of total loans declined to 0.91% from 1.00% YoY, coverage of impaired loans fell to 111.89% from 122.66%, and non-performing loans ratio was nearly flat at 0.57% versus 0.58% prior year. Risks highlighted include potential deterioration in credit card receivables asset quality due to market changes and stricter regulations.
- ·Risk of reduced revenues and deterioration in asset quality of credit card receivables due to market changes and stricter regulation.
- ·Potential national budget deficit from decreased tax revenues or increased government expenditures on stimulus, unemployment, and social programs.
22-04-2026
GXO Logistics, Inc.'s 2026 Proxy Statement solicits votes for the May 20, 2026 virtual annual meeting to elect 10 board directors (9 of 10 nominees independent), ratify KPMG LLP as independent auditors for fiscal 2026, and approve executive compensation on an advisory basis. The document highlights 2025 as a year of record performance and transition, including the appointment of Patrick Kelleher as CEO in August 2025 and Patrick Byrne as non-executive Chairman in January 2026, alongside board refreshment adding independent directors with expertise in automation, technology, and supply chain operations. No declines or flat metrics are disclosed in the provided content.
- ·Annual Meeting date and time: May 20, 2026 at 9:00 a.m. Eastern Time, virtual webcast at https://meetnow.global/M5JFT4M
- ·Record date: April 16, 2026
- ·Street name holders registration deadline: May 15, 2026 at 5:00 p.m. Eastern Time via legalproxy@computershare.com
- ·All current directors independent; Audit, Compensation, Nominating/Corporate Governance/Sustainability, and Operational Excellence Committees entirely independent
- ·Lead Independent Director role complements independent committees
22-04-2026
Vas Infrastructure Limited, currently under Corporate Insolvency Resolution Process (CIRP), has provided prior intimation that the Hon'ble NCLT Mumbai Bench (Court-II) will consider the Resolution Plan submitted by Authum Investment & Infrastructure Limited on May 07, 2026, as per IA no. 41 of 2025. The company is managed by Resolution Professional Ashok Kumar Golechha (IBBI Reg. No. IBBI/IPA-002/IP-N000932/2019-20/12973). This development signals ongoing insolvency proceedings with no financial performance metrics disclosed.
- ·CIN: L65100MH1994PLC076538
- ·Scrip No. 531574
- ·Filing date: April 22, 2026
- ·NCLT matter: IA no. 41 of 2025
- ·RP registration valid upto 31.12.2026
22-04-2026
Yalla Group Ltd reported FY2025 revenues of $341,938 thousand, up a modest 0.7% YoY from $339,676 thousand in FY2024, indicating nearly flat top-line growth after 6.5% growth the prior year. Net income increased 10.4% to $148,140 thousand with stable operating income at $122,217 thousand (up 0.7% YoY), supported by improved cost of revenues margin to 32.8%. However, operating cash flow declined 20.4% to $137,537 thousand from $172,817 thousand, while technology development expenses rose to 10.0% of revenues.
- ·Total employees: 849, with 69.0% in platform maintenance and product development (583), 17.0% in customer services (147).
- ·Cash and cash equivalents: $526,972,019 as of Dec 31, 2025 (up from $488,379,894 in 2024).
- ·Short-term investments increased to $141,251,128 as of Dec 31, 2025 from $70,932,713.
- ·Treasury stock reduced to $(42,497,929) from $(49,438,661), indicating buybacks.
- ·Non-GAAP net income FY2025: $158,457 thousand.
22-04-2026
Axis Trustee Services Limited, acting as onshore security agent, disclosed under SEBI Regulation 29(2) the release of encumbrance over 1,604,258,815 equity shares (5.11% of issued share capital, 5.05% of diluted share capital) of Yes Bank Limited, pledged by Verventa Holdings Ltd, effective April 20, 2026. This reduces the encumbered holding from 1,604,258,815 shares to nil, treated as a disposal. No changes in voting rights or other holdings.
- ·Equity shares have face value of INR 2 each.
- ·Previous disclosures by Axis Trustee Services Limited: 21 July 2023, 14 February 2024, 15 February 2024, 24 October 2024, 29 October 2024.
- ·Shareholding pattern based on quarter ended 31 March 2026.
22-04-2026
Datadog, Inc. converted from a Delaware corporation to a Nevada corporation pursuant to NRS Chapters 78 and 92A, adopting new Articles of Incorporation as Exhibit 3.1 to the 8-K filing. The authorized shares total 2,330,000,000, comprising 2,000,000,000 shares of Class A Common Stock, 310,000,000 shares of Class B Common Stock, and 20,000,000 shares of Preferred Stock, all with a par value of $0.00001 per share. Provisions detail Class B stock rights, including transfer restrictions to preserve voting control for founders Olivier Pomel and Alexis Lê-Quôc, with no financial performance metrics reported.
- ·Board of Directors authorized to issue Preferred Stock in series via Certificate of Designation filed with Nevada Secretary of State.
- ·Class B Common Stock transfer restrictions apply to Qualified Stockholders and Permitted Transferees to maintain Voting Control.
- ·Final Conversion Date defined as 5:00 p.m. NY time on the tenth anniversary of the Effective Time or next Trading Day.
- ·Filing date: April 22, 2026
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →April 15, 2026
US Pre-Market SEC Filings Roundup — April 15, 2026
US Pre-Market SEC Filings Roundup
April 15, 2026
US Merger & Acquisition SEC Filings — April 15, 2026
US Merger & Acquisition SEC Filings
April 15, 2026
US Corporate Board Director Changes SEC Filings — April 15, 2026
US Corporate Board Director Changes SEC Filings
April 15, 2026
US Executive Officer Management Changes SEC — April 15, 2026
US Executive Officer Management Changes SEC